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ABSTRACT
Background: Vaccines against whooping cough (pertussis) and seasonal-influenza are recommended
for pregnant women in England. Uptake however varies regionally and by ethnicity. Pregnant women
are traditionally vaccinated in primary care, though some hospitals now offer vaccines through antenatal
clinics. This mixed-methods evaluation describes the demographic characteristics of women seen in
a hospital midwife-led antenatal vaccine clinic and explores vaccine decision making.
Methods: Descriptive statistics of women seen in a London hospital’s midwife-led vaccine clinic were
generated from electronic routine maternity records, including data on ethnicity, parity, age and
deprivation indices. Reasons for vaccine decline given by women to midwives were categorized by
themes. Qualitative interviews of women seen in the clinic were also undertaken.
Results: Between 1st April 2017 and 31st March 2018 the vaccine clinic saw 1501 pregnant women. Of
these, 83% received pertussis vaccine and (during flu season) 51% received influenza vaccine, from the
clinic. Fewer Black Afro-Caribbean women seen by the clinic were vaccinated, compared to other
ethnicities with only 68% receiving pertussis and 34% flu vaccines respectively (p < .05). Among all
women delivering at the hospital over the year, 42%, (1334/3147) were vaccinated by the clinic.
Qualitative interviews found that reassurance from healthcare professionals, particularly midwives, was
the most important factor influencing maternal vaccine decisions.
Conclusions: Midwife-led hospital clinics can offer an effective alternative to primary care provision for
vaccines in pregnancy. Consistent with previous work, vaccine uptake varied by ethnicity. Midwives play
a key role in the provision of vaccine services and influence women’s vaccine decisions.
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Introduction
In 2012 a pertussis (whooping cough) outbreak was declared in
England following increased incidence and several infant
deaths.1 In response, a maternal pertussis vaccination program
was subsequently introduced nationally.2 Vaccination during
pregnancy can passively protect young infants before they
receive their own routine vaccinations by increasing levels of
transplacentally transferred maternal antibody.3 In the UK, vac-
cination against pertussis is now recommended for all pregnant
women between 16 and 32weeks of pregnancy4 and the program
has been shown to be safe5 and effective in reducing cases of
infant pertussis and the associated morbidity and mortality.6,7
Similarly, seasonal influenza vaccination is recommended for
women at any stage of pregnancy8 to prevent severe illness in
women9 and improve infant outcomes.10,11
Uptake of vaccines in pregnancy – also referred to as maternal
immunization – varies nationally and internationally due to
a number of barriers and influences on the decision to get vacci-
nated in pregnancy.12 Maternal vaccine uptake in England varies
regionally and has been historically lower in London for both
pertussis13-15 and influenza.16 Deprivation and ethnicity are
known predictors of lower maternal pertussis vaccine uptake17,18
as well as for maternal and child influenza vaccine uptake in
England.19 Previous work conducted by our group in London
found low awareness and low maternal pertussis uptake with
variation between different ethnicities, with the lowest uptake
among Black Afro-Caribbean women20 (a demographic group
including Black African/Caribbean/Black British and women of
any other Black background21).
Healthcare professionals and midwives have been found to
be key trusted sources of advice for women’s vaccine
decisions.14,20,22–24 A review of strategies to improve uptake
of maternal vaccines identified vaccine provision by midwives
as an effective strategy to increase coverage of maternal vac-
cines, 25 in concordance with studies outside of the UK which
have also found that midwife-delivered maternal vaccination
clinics can improve vaccine uptake.26–28 Improving maternal
vaccine uptake could additionally enhance uptake of vaccines
in childhood: an Australian study found that vaccine hesitancy
in pregnancy was associated with lower infant vaccine uptake.29
Traditionally in England, pediatric and adult vaccines are
delivered within primary care. Therefore, when maternal
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vaccines were introduced in recent years, they were also
delivered by primary care General Practices (GP). However,
in late 2016 some hospital-based antenatal clinics started to
offer vaccines to pregnant women.13,23 Midwives experienced
in caring for women in pregnancy, were responsible for deli-
vering vaccines in the clinics. However, a lack of data on the
use of non-primary care based clinics for the delivery of
maternal vaccines remains. Accurate estimation of maternal
vaccine uptake, which is estimated from GP records, with this
new model of care has been difficult due to data completeness
issues. Firstly, the denominator of all pregnant women regis-
tered with GPs, used to calculate uptake, is thought to be
incomplete13,16 and secondly, it is unknown how many
antenatally delivered vaccines are accurately recorded in rou-
tine GP records.13,16 A recent commentary summarizing the
literature on maternal vaccination delivery within routine
antenatal care highlighted the potential of the hospital-based
clinic models to improve maternal vaccine uptake in
England.30
We therefore conducted an evaluation of a midwife-led
vaccination clinic, based in a hospital antenatal care setting,
in London. We describe the demographic characteristics of
women who received or declined vaccination from the clinic
and we explored the decision-making process of women who
used the vaccine clinic at the hospital through a number of
qualitative interviews.
Methods
Description of the midwife-led vaccine clinic based within
antenatal service
In December 2016, a clinic was set up at Imperial College
Healthcare NHS Trust to vaccinate pregnant women attend-
ing antenatal clinics. The clinic was midwife-led by two part-
time dedicated ‘vaccine midwives’ (equivalent to one full-time
midwife) who received training on maternal vaccine delivery
and counseling. The vaccine midwives were senior, experi-
enced midwives who had received specific training in the
administration of vaccines and previously worked in both
hospital obstetric and community midwifery roles. Their
role was as solely dedicated vaccine midwives during the
period of the service evaluation, though if staffing levels
were low they would occasionally also see women for routine
hospital appointments in the antenatal clinic. The clinic was
promoted locally, and women could be referred by other
midwives and doctors whilst attending routine antenatal
appointments, self-refer, or be opportunistically approached
by the vaccine midwives in the antenatal waiting rooms. The
vaccine midwives were based in one of the consulting rooms
within the routine antenatal clinic. Some women were seen in
the vaccine clinic on more than one occasion if they initially
declined the vaccine on first contact.
Clinic data analysis
We undertook a one-year clinic evaluation at one hospital site
of The Trust between April 2017 and March 2018. The vac-
cine clinic midwives used a hospital computer based excel
spreadsheet to create a dataset, separate from the woman’s
computerized maternity notes, to record each woman seen in
the vaccine clinic for the purpose of returning data to the
clinic commissioners. This dataset, manually entered by the
vaccine midwives, recorded the date of the interaction, if
women were vaccinated and which vaccines were given. If
women declined vaccination, a brief free-text reason for
declining was recorded. The delivery of any vaccines was
also being recorded as a free text ‘clinic entry’ on each
woman’s hospital maternity records. Women attending the
clinic were asked to inform their GP if they had been vacci-
nated at the hospital.
The dataset underwent cleaning to remove duplicate
entries (see Figure 1) to create the final dataset for analysis,
which reflected each individual woman who was seen by the
clinic. Some duplicate records arose if women were originally
counseled and declined vaccination but then subsequently, at
a later clinic visit, were vaccinated on site. Records of women
which appeared more than once were checked against indivi-
dual electronic hospital records to ensure accuracy of final
allocation.
Demographic data was generated through the hospital
numbers of women seen in the midwife-led clinic and
retrieved from the hospital’s electronic maternity records.
Data was retrieved on the women’s age bracket (not exact
date of birth), estimated due date (used to calculate the
gestation when the women were seen), parity, ‘ethnicity or
familial background’ and whether they understood English.
Postcodes were mapped for each woman to corresponding
Index of Multiple Deprivation 2015 decile, in line with stan-
dard interpretations.31 Postcodes and hospital numbers were
ultimately removed to create the final anonymized dataset for
analysis. Due to some missing data, the gestation at the time
of vaccination could not be calculated for all indivi-
duals (n = 18).
Initial analysis generated overall descriptive characteristics
of all women seen in the vaccine clinic. Ethnicities of women
were compared to the ethnicities of all women delivering at
the hospital site over the same year, as available from the
routine hospital record system.
To estimate the proportion receiving or declining flu vac-
cination the dataset was separated into two, six-month data-
sets (see Figure 1), as flu was only offered for the latter six
months of the year, in line with seasonality. Chi-squared test
of independence was used to determine association between
the different categorical variables such as ethnicity and being
vaccinated by the vaccine clinic. The brief free-text reasons
recorded by the midwives in the spreadsheet for women who
declined vaccination were also categorized and tabulated.
Qualitative interviews
Participants, sampling & recruitment
Participants for interviews were women aged over 18 years
receiving (or having recently received) antenatal care at the
same hospital, who had been seen by the vaccine midwives.
A convenience sample was used, and women were recruited
by being approached by one of the vaccine midwives in the
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antenatal clinic waiting area and given an invitation letter and
the participant information sheet. Women who expressed an
interest in participating were contacted directly by the
researcher for further explanation. Written informed consent
was obtained prior to participation. For the interviews, ethical
approval was received from the local Hampstead Research
Ethics Committee, London, reference number: 13/LO/1712.
Interviews
An Interpretative Phenomenological Analysis (IPA) approach32
was used to enable participants to offer a rich, detailed, first-
person account of their experiences33 and to understand how
they approached vaccine decisions in pregnancy. Research ques-
tions in IPA focus upon people’s understanding of their experi-
ences and are framed broadly and openly.32
Interview data was derived from either recorded telephone
interviews with one researcher (a midwife) or a face-to-face
discussion that was recorded between two women and the
same midwife researcher. The interview process consisted of
open-ended questions which were developed drawing on pre-
vious research.20 All main points raised by each participant
were summarized at the end of the discussion by the
researcher, giving women the opportunity to add or amend
as required.
Qualitative interviews data analysis
Interview transcripts were analyzed according to the princi-
ples of IPA using an iterative approach. This involved multi-
ple readings and note making, transforming notes into
emergent themes, before trying to identify relationships and
clustering themes.32,34 Each transcript was re-read several
times and analyzed in its entirety before moving onto the
next by the same midwife researcher (BD) who interviewed
the women.
Results
Clinic use
Between 1st April 2017 and 31st March 2018, 1710 entries of
women seen in the clinic were recorded. Of these, 1429 entries
showed vaccines administered and 281 vaccination being
declined. Following duplicate removal, 1501 unique pregnant
women’s records remained, (see Figure 1). Between 1st April
Entries removed as recorded women already 
vaccinated (n=20)
Duplicate entries removed  - if women were originally 
counselled and declined vaccination but then 
subsequently, at a later visit, accepted vaccination, 
then first record in the declined dataset was removed 
and their received entry recoded to ‘Received Post 
Counselling’ (‘RPC’) (n=56). 
Duplicate entries removed – if women appeared twice 
as received vaccines separately then flu vaccine 
receipt entry removed and pertussis vaccine entry 
recoded as (S) and gestation flu given added to 
pertussis entry. (n=83) 
April 2017-Sep 2017 
n= 788 
Oct 2017-March 2018 
n= 713 
Dataset of unique women using midwife-led 
vaccine clinic (n = 1501)
Remaining records (n= 1690)
Vaccine Clinic Dataset 
(n=1,710) 
Remaining records (n= 1634)
Remaining records (n= 1551)
Final cleaning & removal of duplicate entries:  
o Declined twice (n=3) 
o Women with triplicate entries (n=13) 
o Recorded as declined one vaccine & 
received other, (received entry 
recoded) (n=26) 
o Incorrectly recorded as received at 
GP (n=1) 
o Duplicate entries (e.g. same 
day/same woman/same vaccine) 
(n=7) 
Figure 1. Consort diagram summarizing the final dataset creation for analysis.
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and 31st September 2017, the vaccine midwives saw 788
women; between 1st October 2017 and 31st March 2018, 713
women were seen. The completeness of the data differed
between variables (supplementary tables 2–4).
Women seen in the midwife-led, antenatal maternal
vaccine clinic
Between 1st April 2017 and 31st March 2018, 3147 women
delivered at the hospital site. Of all women delivering at the
hospital, 48% (n = 1501/3147) were seen in the clinic over this
time period. Overall, 89% (n = 1334/1501) received one or
two maternal vaccines (for full breakdown, see supplementary
table 1). Therefore, 42% of all women delivering at the hospi-
tal between April 2017 and March 2018 received one or more
maternal vaccines via the vaccine clinic (1334/3147 deliveries).
Four percent of women (n = 56), received counseling by the
vaccine midwives during an earlier appointment and prior to
the date when they were eventually vaccinated.
The ethnicity profile of women seen in the vaccine clinic
was comparable to all women delivering at the hospital site
during the same time period (Table 1). In 33%, ethnicity was
not recorded. Of women seen in the clinic, 4% (n = 63) were
recorded as not understanding English, of which 11%
declined vaccination from the clinic.
According to IMD decile ranking, 48% of all women seen
in the clinic lived in neighborhoods among the 30% most
deprived in England and 28% of women lived in the 20%
most deprived areas (supplementary table 2). Fifty
four percent were primiparous and the majority (79%) were
aged 26–39 years (supplementary tables 3 & 4). On average,
women were seen in the vaccine clinic at 25 weeks gestation
(range 6–40 weeks).
Pertussis vaccine
Over the entire observation period, 83% of women seen
(n = 1252/1501) were vaccinated against pertussis by the
antenatal vaccine service.
Flu vaccine
During flu season, 51% (n = 360/713) of women were vacci-
nated against flu by the antenatal vaccine service. Forty
women who were vaccinated with pertussis vaccine by the
clinic between April and September 2017 also went onto
receive their flu vaccine there later in pregnancy, when they
became eligible in the flu season.
Overall, 15% (n = 43) received pertussis and flu vaccines at
separate appointments. During flu season, 11% of women
(n = 75) received neither pertussis vaccine nor seasonal flu
vaccine.
Demographic variation in vaccine receipt
10% of women (n = 155) seen by the clinic were Black-Afro
Caribbean (including women of mixed black ethnicities). Only
68% of these women seen in the clinic received pertussis
vaccine compared to over 80% of women seen from other
ethnicities (Figure 2, p < .05). During flu season (Oct 2017-
Mar 2018) only 36% of Black-Afro Caribbean women received
flu vaccine compared to an average of 51% of women from
other ethnicities (Figure 3, p < .05).
Vaccine receipt was found to be significantly associated
with parity: overall, 19% of women of higher parity (greater
than 2) declined vaccination compared to 9% of women
who were pregnant with their first or second child (supple-
mentary table 5, p < .05). A higher percentage of women
aged 16–25 years (17%) declined maternal pertussis vaccine
compared to those aged over 25 years (10%), however this
did not reach statistical significance (supplementary table
6, p > .05).
Declining or receiving vaccination was not found to be
independently associated with deprivation (p ≤ 0.05).
However, overall a higher proportion of Black Afro-
Table 1. Ethnicities of all women delivering at the hospital compared to all
women recorded as using the midwife led maternal vaccine clinic.
Ethnicity
All Hospital Deliveries April 2017-
March 2018
Vaccine Clinic
April 2017 –
March 2018
Unknown 33% 33.0%
White 25% 28.8%
Black 11% 9.3%
Asian 13% 11.7%
Mixed 2% 2.7%
Other 16% 14.5%
Total Number of
Women
3147 1501
Unknown = ‘Not Stated’ & ‘Not known’.
White = White British, White Irish and Other White Background.
Black = Black or Black British African, Caribbean and Any other Black
Background.
Asian = Asian or Asian British Indian, Pakistani, Bangladeshi or any other Asian
Background and Chinese.
Mixed = Mixed – White and Black Caribbean, Mixed – White and Black African,
Mixed – White and Asian, Mixed – Any Other Mixed Background
Other = Any other ethnic group.
Table 2. Reasons recorded for women who declined vaccination from the
maternal vaccine clinic Oct 2017-March 2018.
Reason for declining Vaccines
Number of
women
% all women
declining
Declined for personal reasons 36 22%
Declined as wants time to consider decision. 32 19%
Declined but no reason given. 28 17%
Declined as does not believe in vaccinations or
does not believe in vaccinations in
pregnancy.
26 16%
Declined as wanted to defer until after next app
or until after scan or after anti-d injection.
8 5%
Declined as wanted more information on the
vaccine and whether safe to have vaccine.
6 4%
Deferred today as felt unwell. 6 4%
Declined as family, friends or husband advised
not to get vaccines in pregnancy.
4 2%
Declined – as thought they could not have
vaccines as (for example ‘had allergies’).
4 2%
Declined due to language barrier 3 2%
Declined flu only. 3 2%
Declined pertussis only due to previous bad
reaction to flu vaccine.
3 2%
Declined as would prefer to organize to have at
their GP.
2 1%
Declined as scared of needles. 2 1%
Declined as felt unwell. 1 1%
Declined as chargeable overseas visitor. 1 1%
Total 167
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Figure 2. Pertussis vaccine receipt by ethnicity April 2017-March 2018.
Percentage of women in each ethnic group who received maternal pertussis vaccine from the antenatal clinic April 2017- March 2018. Chi-Square Test of Independence of
association between ethnicity and vaccine receipt, p = <0.05. Asian = Asian or Asian British Indian, Pakistani, Bangladeshi or any other Asian Background and Chinese
(n = 176) Black = Black or Black British African, Caribbean and Any other Black Background, Mixed – White and Black Caribbean, Mixed – White and Black African.
(n = 155).(Note mixed Black ethnicity included within Black ethnicity group) White = White British, White Irish and Other White Background. (n = 432)
Mixed = Mixed – White and Asian, Mixed – Any Other Mixed Background (n = 24) Other = Any other ethnic group. (n = 218) Unknown = Other ‘Not Stated’ &
Other ‘Not known’. (n = 496) Overall = 1501
Figure 3. Seasonal flu vaccine receipt by ethnicity October 2017-March 2018.
Percentage of women in each ethnic group who received seasonal flu vaccine from the clinic October 2017-March 2018. Chi-Square Test of Independence of association
between ethnicity and vaccine receipt, p = <0.05.Asian = Asian or Asian British Indian, Pakistani, Bangladeshi or any other Asian Background and Chinese (n = 69)
Black = Black or Black British African, Caribbean and Any other Black Background, Mixed – White and Black Caribbean, Mixed – White and Black African. (n = 67)
(Note mixed Black ethnicity included within Black ethnicity group)White = White British, White Irish and Other White Background. (n = 208)Mixed = Mixed – White and
Asian, Mixed – Any Other Mixed Background (n = 18)Other = Any other ethnic group. (n = 97)Unknown = Other ‘Not Stated’ & Other ‘Not known’. (n = 254)Overall
(n = 713)
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Caribbean or Mixed-Black Afro-Caribbean ethnicity women
lived in deprived areas. Of Black Afro-Caribbean women,
79% lived in neighborhoods among the 40% most deprived
in England (IMD score 1–4) compared to 56% of white
women.
Free-text reasons recorded for declining
The four most common reasons recorded for women declin-
ing vaccination were ‘Declined for personal reasons’ (36/
167,22%), ‘Declined as wanted time to consider’ (32/167,
19%), ‘No reason given’ (28/167,17%) and ‘Not believing in
vaccines or vaccines in pregnancy’ (26/167, 16%), (Table 2).
Qualitative interviews results
Characteristics of women participants
A total of 10 women aged 29 to 44 years and from diverse
ethnic backgrounds were recruited for interviews, of whom
three had declined and seven had received pertussis vaccina-
tion during pregnancy. Six women were nulliparous and four
multiparous. Eight were pregnant at the time of interview,
with gestations ranging from 27 to 38 weeks, and two women
were postnatal.
Attitudes to vaccination
Four main themes arose from the analysis of influences on
decision making with regards to maternal vaccination as out-
lined below using example quotes.
1. Interactions with midwives and health care
workers
2. Perceived risk of disease and vaccines
3. Beliefs and experiences
4. Trust or distrust in ‘system’
The first key theme that arose was how interactions with
health care workers influenced women’s vaccination deci-
sions. For some women, healthcare workers were seen as
knowledgeable, enthusiastic and warm but some women
were unhappy with the routine nature of the information
provided. Secondly, women’s perceived risks of the vaccine
or the disease itself were important factors. For some women
the risk of the disease meant they accepted vaccination,
whereas others perceived the risks of the vaccine to be too
high and they declined vaccination. Thirdly, beliefs and
experiences were important influences, either meaning
women believed in vaccines or that their ‘holistic’ beliefs
meant they declined vaccination. Finally, the women’s trust
in the wider public health system were important factors that
influenced their decision making with some viewing it
‘I could tell that the midwife had a lot of information and if there was anything
that she didn’t know, she didn’t mind finding out and that gave me a great
deal of reassurance. I had trust in the advice they gave me, reinforced by their
competence”
(vaccinated participant)
‘I didn’t know about it actually, so, I wasn’t thinking about it when I met the
midwife at 14 weeks into my pregnancy. She told me all about it (the vaccine)
and she was really excited about telling me. It was good,’
(vaccinated participant)
‘when I first met the midwife, they talked about the vaccine. I was given the
materials and they asked me to do it that day. I think maybe I was about 16 or
17 weeks, but I didn’t do it immediately because I didn’t know about it … .i
wanted to learn more about it’
(vaccinated participant)
‘I spoke to the midwife again and she explained things more clearly to me and
made me feel confident about taking the vaccine.’
(vaccinated participant)
“Women would really like to get straight answers from professionals so that
they can make a truly informed decision”
(vaccinated participant)
“The quality of the doctor makes a massive difference. I have been seeing some
junior doctors and I have been incredibly disappointed with how little they
know and how very unwilling they are to go ‘off script’, for example, if I ask
them a question about my previous illness, they just look at me like a damsel
in distress and say well we can’t answer the question because we don’t know
the side-effects. This has been a rather big factor in my decision not to have
the vaccine”.
(unvaccinated participant)
“I knew that if I didn’t have the vaccine my baby would be at more risk, so, I felt
the risk of the baby actually getting the whooping cough and the impact of
that far outweighed any risk from the vaccine”.
(vaccinated participant).
“vaccines undermine parts of our immune system, so, if you don’t have them
you are at less risk of catching infections as the immune system works better”.
(unvaccinated participant)
“Maybe one factor that would have taken away the fear of having the
vaccine … .was when they gave me the leaflet. If they had said ‘here are the
statistics … . last year X number of women had the vaccine and X number of
women suffered side-effects as a consequence’ then, that sort of information
might have encouraged me to take the vaccine… if I knew it was safe. If I had
known that there were no real problems then that would have been helpful”.
(unvaccinated participant)
‘I am not willing to take ‘the risk’ to do it.’
(unvaccinated participant)
“I remember my mum had whooping cough years ago, it was awful and I know
that it can be deadly for little ones, so, I just wouldn’t want to put my baby
through that or myself … you know … . It’s like self-preservation and baby
preservation … it just makes sense to me to have the vaccine”.
(vaccinated participant)
“we believe that you have the vaccinations because we have faith in the Public
Health System acting in the best interests of the public”
(vaccinated participant)
“I believe in vaccines anyway as a scientist”
(vaccinated participant)
“A lot of people just don’t understand what whooping cough is”
(vaccinated participant)
“I believe very much about the holistic approach to everything”.
(unvaccinated participant)
“If the whole system of vaccination and the possible negative effects of
vaccination were more transparent and the public were more aware about
particular (although rare) results of vaccination then the doctors and the NHS
and the drugs companies need to be more responsible with regards to the
negative outcomes. The issue of transparency is huge it is creating a certain
level of distrust which is having a huge impact on vaccine acceptance”.
(unvaccinated participant)
“we have faith in the Public Health System acting in the best interests of the
public”
(vaccinated participant)
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negatively and declining vaccination whilst others trusted the
system and were vaccinated. Based on the thematic analysis of
the interview transcripts women could be characterized into
three categories, reflecting their approach to vaccine decision-
making: pro-vaccination, anti-vaccination and the hesitant-
complier (see supplementary, table 7).
Discussion
Our findings support hospital-based midwife-led antenatal
clinics as a model that can make an important contribution
to maternal vaccination programs. We believe that this is the
first evaluation to describe the demographics of women seen
in a hospital based midwife-led maternal vaccine clinic in
England. By extracting routinely collected data from electro-
nic hospital maternity records we were able to analyze records
of over 1500 women. Of women who were seen in the vaccine
clinic, 89% were ultimately vaccinated by the service (with
either flu or pertussis). Vaccine receipt among women how-
ever was not universal, as a higher proportion of Black Afro-
Caribbean women declined vaccination from the clinic, in line
with national data on maternal immunization uptake.17 We
also report a lower uptake in women of higher parity.
The ethnicity profile of women seen in the vaccine clinic
was representative of the overall ethnically diverse local
maternity population who deliver at this hospital. Thus, we
believe that our findings are relevant to other diverse urban
populations with antenatal clinics providing maternal vac-
cines. By combining quantitative and qualitative data derived
from the same setting, our descriptive evaluation is able to
provide a picture of both the demographics and the attitudes
to vaccine decision making among pregnant women.
Our original study from 2015 found low (26%) maternal
pertussis uptake at the same hospital,20 and uptake has clearly
improved nationally overall since the introduction of the
maternal pertussis programme in 2012.35 Between
April 2017 and March 2018, the average national maternal
pertussis vaccine uptake reported by Public Health England
was 72%, but only 60% in Greater London.35 In two clinical
commissioning group areas local to the hospital, the reported
uptake was even lower at 52%,36 though it is acknowledged
that these figures might underestimate coverage.35 The
reported estimated national and regional seasonal influenza
vaccine uptake among pregnant women is generally lower
than uptake of the pertussis vaccine16 for example, local
clinical commissioning groups reported influenza vaccine
uptake of only 39% among pregnant women for the same
time period.37
During the time period studied, the vaccines delivered by
the hospital-based clinic were not being automatically
recorded in GP records, as there was no direct data link
between the vaccine clinic and general practice. Women
attending the clinic were asked to inform their GP. As
a consequence, women vaccinated by the clinic might have
been missed in the reported regional or national statistics,
which come from GP records. Following our study period,
a letter notifying GPs of vaccination started to be sent by the
clinic as a matter of routine. In order to fully evaluate the
impact of antenatal maternal vaccine clinics in England,
hospital-based delivered vaccines should be accurately
reported within national maternal vaccine estimates, which
remain based on GP surveillance data. Whilst our evaluation
does not provide local population-level uptake estimates, it
does support previous findings of the effectiveness of mid-
wife-delivered vaccine models.25,30,38 A recently reported sur-
vey of UK GPs also found that there was support among GPs
for antenatal services to deliver maternal vaccine programs in
England.39
Other investigators have previously reported on vaccine
clinics based within maternity services, for example Green
et al. described a midwife clinic based in Lewisham and
Greenwich NHS Trust.23 However, the authors did not ana-
lyze the demographics of women using the clinic nor reasons
for acceptance or declining vaccination from the clinic.
A recently reported feedback survey of one hundred women
using an antenatal vaccine clinic in England found that 61%
endorsed antenatal appointments as the optimal place for
vaccine delivery during pregnancy.30 Studies outside of the
UK have also found that midwife delivered maternal vaccina-
tion models are able to improve maternal vaccine
uptake.26,27,40,41 Mohammed et al, reported that a midwife
delivered maternal vaccine program in Australia improved
uptake in a hospital population26 but studies have not
reported on the impact of midwife provision on overall
national maternal vaccine uptake rates.
We and others have previously identified midwives and other
healthcare professionals as key influencers in women’s vaccine
decisions in pregnancy.14,20,22–25 Our evaluation supports this,
given the high proportion of women who received vaccines from
midwives at the clinic. Nearly twenty percent of women who
declined vaccines from the clinic wanted more time to consider.
Four percent of women who initially declined were vaccinated at
a subsequent appointment, highlighting the importance of
ongoing conversations with midwives in supporting women’s
pregnancy vaccine decisions. Three of the women who partici-
pated in the qualitative interviews were categorized as ‘hesitant-
compliers’, further supporting the notion that conversations with
trustedmidwives are important in vaccine decisionmaking during
pregnancy.22–24 Consistent with our findings, previous qualitative
research into vaccine decision making has also highlighted the
importance of offering vaccines through non-traditional settings
to overcome some parental vaccine hesitancy.42 Midwives should
therefore receive training and support to enable them to promote
vaccination among pregnant women.43,44
In line with our research in 2015,20 our evaluation con-
tinues to show that Black Afro-Caribbean women are less likely
to be vaccinated in pregnancy, and a midwife-led service did not
appear to resolve this issue. This finding is also consistent with
previous studies in different international contexts.12,18,20,45 In
England, Byrne et al. found that women of Black-British and
Black-Afro-Caribbean ethnicity had the lowest maternal pertus-
sis vaccine coverage and reported that deprivation was linked to
low maternal vaccine coverage.17 Black-Afro Caribbean
women’s vaccine hesitancy might relate to wider feelings of
discrimination by the healthcare system associated with ethnicity
and socio-economic deprivation.12,24,46 Further research and
community engagement are required to better understand the
underlying reasons. Delivery of maternal vaccines has
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implications beyond the perinatal period as factors underlying
suboptimal childhood vaccination in England maybe similar to
maternal vaccination factors.17,47 Attitudes toward maternal
vaccines have been found to correlate with acceptancy of child-
hood vaccination,29 and Black-Afro Caribbean ethnicity is also
known to be associated with lower childhood vaccine uptake in
the UK.46,48 Early, targeted interventions during pregnancy
among ethnic minority groups with known lower vaccine uptake
could therefore maximize both maternal and childhood vaccine
uptake.
McAuslane et al., reported that maternal vaccine receipt in
pregnancy in England was associated with ethnicity, depriva-
tion and also parity.18 We did not find that deprivation was
associated with maternal vaccine uptake, however we cannot
know if more deprived women were less likely to visit the
vaccine clinic in the first place. In agreement with McAuslane
et al., we also found that more women of higher parity
declined vaccination when seen in the clinic compared to
women of lower parity.
Our study has some clear limitations: we do not know the
number of women vaccinated in primary care during the
same time period. This is because we did not have access to
the GP records of the women attending the clinic or who
delivered at the hospital. Therefore, we cannot provide total
vaccine uptake estimates for the whole hospital population.
We can only report on the number of women who received or
declined vaccines from the antenatal clinic.
Some limitations arise from the use of routine data where for
example, ethnicity was not recorded in a third of the women.
This may have led to over or underestimation of the association
between ethnicity and vaccine receipt. However, given that this
percentage is identical for all women recorded as delivering at
our hospital, we believe that our sample is representative.
Our results might be subject to selection bias: women who
were more likely to decline vaccinations may also have been less
likely to be seen in the vaccine clinic in the first place. However,
it is important to note that the vaccine midwives were actively
approaching women in the antenatal clinic. Women attending
the antenatal vaccine clinic could have come from more affluent
backgrounds which might explain why in contrast to other
studies we did not find an association between deprivation and
maternal vaccination.17 The number of women who participated
in the qualitative interviews was small, but this is often the case
in qualitative studies. Women living in more deprived areas and
not speaking English as a first language were possibly less likely
to have agreed to take part in the qualitative interviews.
Conclusion
In conclusion, our data supports the significant role of mid-
wives and antenatal clinics in delivering maternal vaccination
programmes. Over 40% of all women who delivered at this
urban hospital received their vaccines via this antenatal clinic.
Uptake in the antenatal vaccine clinic was much higher than
the locally reported pertussis vaccine uptake estimates. Our
evaluation therefore supports antenatal based midwife-led
vaccine clinics as a model that could increase vaccination
rates in pregnancy. Further work is needed to understand
the relationship between ethnicity and vaccine confidence in
England. Accurate tracking of antenatally delivered vaccines
between hospital-based services and primary care will be
essential to appreciate the full impact of novel models of
vaccine delivery on uptake rates.
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